Cencora, Inc.
Close on Nov 20, 2026Market cap $64.71BP/E 25.2Yield 0.65%
Cencora Peer Benchmark: Option Care Health, Inc. (OPCH) by Quarter
Peer Benchmark: Option Care Health, Inc. (OPCH) — Consolidated Revenue ($M) ($M)
Cencora Peer Benchmark: Option Care Health, Inc. (OPCH): $1,442M in Q3 FY26, up 1.9% from a year earlier. That is the highest of the 52 quarters on record here.
Where the Q3 FY26 figure comes from
“OPCH us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax = $1,442,400,000 (2026-04-01 to 2026-06-30)”
Source: SEC EDGAR XBRL CompanyFacts (OPCH) ↗
SEC XBRL quarterly and annual benchmark for alternate-site / infusion services peer Option Care Health, Inc. (CIK 0001014739, aligned to Cencora's fiscal calendar).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Peer Benchmark: Option Care Health, Inc. (OPCH) — Consolidated Revenue ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 FY26CQ2 2026 | Jun 30, 2026 | 1,442 | +1.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY26CQ1 2026 | Mar 31, 2026 | 1,351 | +1.3% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY25CQ3 2025 | Sep 30, 2025 | 1,435 | +12.2% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY25CQ2 2025 | Jun 30, 2025 | 1,416 | +15.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY25CQ1 2025 | Mar 31, 2025 | 1,333 | +16.3% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY24CQ3 2024 | Sep 30, 2024 | 1,279 | +17.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY24CQ2 2024 | Jun 30, 2024 | 1,227 | +14.8% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY24CQ1 2024 | Mar 31, 2024 | 1,146 | +12.8% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY23CQ3 2023 | Sep 30, 2023 | 1,093 | +7.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY23CQ2 2023 | Jun 30, 2023 | 1,069 | +9.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY23CQ1 2023 | Mar 31, 2023 | 1,016 | +10.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY22CQ3 2022 | Sep 30, 2022 | 1,021 | +14.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY22CQ2 2022 | Jun 30, 2022 | 981 | +14.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY22CQ1 2022 | Mar 31, 2022 | 916 | +20.6% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY21CQ3 2021 | Sep 30, 2021 | 892 | +14.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY21CQ2 2021 | Jun 30, 2021 | 860 | +16.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY21CQ1 2021 | Mar 31, 2021 | 759 | +7.6% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY21CQ4 2020 | Dec 31, 2020 | 805 | +11.6% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY20CQ3 2020 | Sep 30, 2020 | 782 | +26.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY20CQ2 2020 | Jun 30, 2020 | 741 | +49.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY20CQ1 2020 | Mar 31, 2020 | 705 | +48.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY20CQ4 2019 | Dec 31, 2019 | 721 | +42.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY19CQ3 2019 | Sep 30, 2019 | 616 | +24.7% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY19CQ2 2019 | Jun 30, 2019 | 497 | +3.7% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY19CQ1 2019 | Mar 31, 2019 | 477 | +3.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY19CQ4 2018 | Dec 31, 2018 | 506 | +176.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY18CQ3 2018 | Sep 30, 2018 | 494 | +148.6% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY18CQ2 2018 | Jun 30, 2018 | 480 | +119.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY18CQ1 2018 | Mar 31, 2018 | 461 | +111.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q1 FY18CQ4 2017 | Dec 31, 2017 | 183 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY17CQ3 2017 | Sep 30, 2017 | 199 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY17CQ2 2017 | Jun 30, 2017 | 218 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY17CQ1 2017 | Mar 31, 2017 | 218 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY14CQ3 2014 | Sep 30, 2014 | 244 | +28.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY14CQ2 2014 | Jun 30, 2014 | 247 | +43.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY14CQ1 2014 | Mar 31, 2014 | 239 | +32.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY13CQ3 2013 | Sep 30, 2013 | 191 | +11.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY13CQ2 2013 | Jun 30, 2013 | 172 | +10.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY13CQ1 2013 | Mar 31, 2013 | 181 | +16.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY12CQ3 2012 | Sep 30, 2012 | 170 | +27.4% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY12CQ2 2012 | Jun 30, 2012 | 156 | +18.5% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY12CQ1 2012 | Mar 31, 2012 | 156 | +19.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY11CQ3 2011 | Sep 30, 2011 | 134 | -69.7% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY11CQ2 2011 | Jun 30, 2011 | 132 | -68.1% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY11CQ1 2011 | Mar 31, 2011 | 131 | -61.0% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY10CQ3 2010 | Sep 30, 2010 | 441 | +32.3% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY10CQ2 2010 | Jun 30, 2010 | 412 | +25.3% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY10CQ1 2010 | Mar 31, 2010 | 335 | +2.9% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY09CQ3 2009 | Sep 30, 2009 | 334 | -7.2% | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q3 FY09CQ2 2009 | Jun 30, 2009 | 329 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q2 FY09CQ1 2009 | Mar 31, 2009 | 326 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
| Q4 FY08CQ3 2008 | Sep 30, 2008 | 359 | – | SEC EDGAR XBRL CompanyFacts (OPCH) ↗ |
Breakdown
What makes up peer Benchmark: Option Care Health, Inc. (OPCH)
Cite this data
StockData. (2026). Cencora Peer Benchmark: Option Care Health, Inc. (OPCH) ($M), quarterly Q4 FY08–Q3 FY26 [Data set]. Compiled from Cencora SEC filings and investor materials. https://stockdatahq.com/stocks/cor/kpis/peer-opch-rev
See every metric in the Cencora KPI table. Data updated Nov 7, 2026.
See a number that looks wrong?